CASE REPORT
When rarity meets complexity - Schimke immuno-osseous dysplasia with nephrotic syndrome: a 15-year longitudinal case report
More details
Hide details
1
Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland
2
Foundation of Prof. Jerzy Sadowski HEART for KNOWLEDGE, Cracow, Poland
3
Department of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College, Cracow, Poland
Submission date: 2025-10-25
Final revision date: 2026-01-02
Acceptance date: 2026-01-08
Publication date: 2026-06-30
Pediatr Pol 2026;62(2):198-204
KEYWORDS
TOPICS
ABSTRACT
Schimke immuno-osseous dysplasia (SIOD) is an exceptionally rare autosomal recessive disorder caused by pathogenic variants in the SMARCAL1 gene and characterised by spondyloepiphyseal dysplasia, immuno- deficiency, and progressive renal disease, often presenting as steroid-resistant nephrotic syndrome. Fewer than 100 cases have been reported worldwide. This manuscript describes a male patient with genetically confirmed SIOD, monitored age 4.5–19 years. Early features included growth failure, hyperpigmentation, skeletal abnormalities, moderate T-cell lymphopaenia, and biopsy-proven focal segmental glomerulosclerosis. In adolescence, the disease transitioned to a severe phenotype with end-stage renal disease, recurrent infections, bone marrow failure, and Evans syndrome, reflecting profound immune dysregulation. Despite multidisciplinary management, including renal-replacement therapy and individualised immunological care, the patient’s condition progressively deteriorated and he ultimately died from multi-organ failure. This long-term observation illustrates the evolving natural history of SIOD and the shift from renal disease in childhood to combined immunodeficiency and haematological complications in adolescence.
REFERENCES (15)
1.
Boerkoel CF, Takashima H, John J, Yan J, Stankiewicz P, Rosenbarker L, et al. Mutant chromatin-remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet 2002; 30: 215-220.
2.
Hunter KB, Lücke T, Spranger J, Smithson SF, Alpay H, André JL, et al. Schimke immuno-osseous dysplasia: defining skeletal features. Eur J Pediatr 2009; 169: 801-811.
3.
Saraiva JM, Dinis A, Resende C, Faria E, Gomes C, Correia AJ, et al. Schimke immuno-osseous dysplasia: case report and review of 25 patients. J Med Genet 1999; 36: 786-789.
4.
Castellano-Martínez A, Acuñas-Soto S, Varga-Martínez R, Rodríguez-González M, Mora-López F, Iriarte-Gahete M, et al. Different phenotypes of Schimke immuno-osseous dysplasia (SIOD) in two sisters with the same mutation in the SMARCAL1 gene. Endocr Metab Immune Disord Drug Targets 2022; 22: 888-894.
5.
Milovanova A, Ananin P, Vashurina T, Zrobok O, Dmitrienko S, Ryaposova A, et al. Genetic and clinical features of Schimke immuno- osseous dysplasia: a retrospective study of 21 paediatric patients. Int J Mol Sci 2025; 26: 1744.
6.
Zieg J, Bezdíčka M, Němčíková M, Balaščáková M, Suková M, Štěrbová K, et al. Schimke immuno-osseous dysplasia: an ultra-rare disease. Ital J Pediatr 2023; 49: 11.
7.
Zachwieja K, Moczulska A, Miklaszewska M, Wierzchowska-Słowiaczek E, Ogarek I, Kwinta-Rybicka J, et al. Schimke syndrome (Schimke immuno-osseous dysplasia – SIOD) as a rare cause of nephrotic syndrome. Nefrol Dial Pol 2013; 17: 37-41.
8.
Bertulli C, Marzollo A, Doria M, Di Cesare S, La Scola C, Mencarelli F, et al. Expanding phenotype of Schimke immuno-osseous dysplasia: congenital anomalies and NK cell alterations. Int J Mol Sci 2020; 21: 8604.
9.
Sarin S, Javidan A, Boivin F, Alexopoulou I, Lukic D, Svajger B, et al. Renal pathogenesis in Schimke immuno-osseous dysplasia: histological characterization and expression analysis. J Histochem Cytochem 2015; 63: 32-44.
10.
Xiong S, Huang Y, Mo Y, Wang J, Huang L, Jiang X, et al. Podocytic infolding in Schimke immuno-osseous dysplasia with novel SMARCAL1 mutations: a case report. BMC Nephrology 2020; 21: 143.
11.
Tarantini F, Cumbo C, Anelli L, Zagaria A, Conserva MR, Redavid I, et al. Exploring the potential of eltrombopag: room for more? Front Pharmacol 2022; 13: 906036.
12.
Vladyka O, Zieg J, Pátek O, Bloomfield M, Paračková Z, Šedivá A, et al. Profound T-lymphocyte and DNA repair defect characterizes Schimke immuno-osseous dysplasia. J Clin Immunol 2024; 44: 180.
13.
Bucciol G, Tangye SG, Meyts I. COVID-19 in patients with inborn errors of immunity: lessons learned. Curr Opin Pediatr 2021; 33: 648-656.
14.
Fischer A, Provot J, Jais JP, Alcais A, Mahlaoui N. Autoimmune and inflammatory manifestations in primary immunodeficiencies. J Allergy Clin Immunol 2017; 140: 1388-1393.e8.
15.
Aladjidi N, Pincez T, Rieux-Laucat F, Nugent D. Paediatric-onset Evans syndrome: breaking away from refractory immune thrombocytopenia. Br J Haematol 2023; 203: 28-35.